4180026/2025-SELPERCATINIB 40 MG CAPSULES
About This Opportunity
TranslatedThis tender, reference number 4180026/2025, is specifically for the supply of Selpercatinib 40 mg capsules. Selpercatinib is a targeted therapy drug used in the treatment of certain types of cancer, particularly those with specific genetic alterations such as RET fusions or mutations. The procurement aims to ensure the availability of this critical medication for patients undergoing cancer treatment. The contracting authority is seeking a reliable supplier capable of providing the specified pharmaceutical product in the required quantities and according to stringent quality standards. Bidders must be authorized to distribute pharmaceutical products and must comply with all national and international regulations governing the supply of medicines. The tender documents will outline the exact specifications, including dosage form, strength, packaging, and delivery requirements. Potential suppliers are expected to provide evidence of their regulatory compliance, product quality assurance, and supply chain integrity. This procurement is vital for providing advanced oncological treatment options to patients. Interested parties should thoroughly review the tender details, including any specific requirements for pharmacovigilance and product traceability.
This is a supplies contract in the health and medical services, trade and industry and Monitoring Evaluation sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 4,337.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, identified by reference 4180026/2025, concerns the procurement of Selpercatinib 40 mg capsules. The contracting authority, operating within Portugal, is seeking to acquire this pharmaceutical product through a public tender process. The Portal BASE, which centralizes information on public contracts in mainland Portugal and its autonomous regions, is the platform for this procurement.
Selpercatinib is a targeted therapy medication used in oncology. As such, this tender is for the supply of a specific pharmaceutical formulation, indicating a need for a reliable and compliant supplier within the healthcare sector. Typical requirements for tenders of this nature include adherence to stringent quality standards, Good Manufacturing Practices (GMP), and relevant regulatory approvals from national and European health authorities. Bidders are generally expected to demonstrate their capacity to supply the specified quantity of medication, maintain product integrity throughout the supply chain, and provide comprehensive documentation regarding product origin, batch traceability, and expiry dates. Furthermore, proposals often necessitate detailed pricing structures, delivery timelines, and potential service level agreements. Interested parties should review the full tender documentation, which will be made available through the specified procurement portal, for precise specifications, evaluation criteria, and submission deadlines.
This procurement underscores the commitment of the Portuguese public health system to acquiring essential and advanced medical treatments.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 9, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Arco Ribeirinho, EPE
Unidade Local de Saúde do Arco Ribeirinho, EPE has issued 360 procurement notices on BidsFactory, including 0 currently open and 333 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Arco Ribeirinho, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €4,337. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to LILLY FARMA, LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.